Fatigue is associated with a number of clinical diseases, including chronic pain conditions such as chronic fatigue syndrome and fibromyalgia (4; 13; 36; 37; 39; 64; 67; 70; 71; 73) . In these chronic conditions, fatigue is generally described as a whole body feeling of muscle fatigue and loss of energy. Fatigue, experimentally, is defined as a temporary decrease in muscle force in response to exercise (19) . In patients with chronic fatigue syndrome or fibromyalgia exhibit an enhanced fatiguing response to exercise (57) as well as muscle weakness and decreased endurance (33; 34; 69) suggesting potential interactions between fatigue and pain. Many peripheral factors affect muscle fatigue including differences in local metabolic changes, sex, and muscle fiber types and these factors may interact to either enhance or protect against fatigue (19) .
Changes in the extracellular environment directly affect muscle fatigability. Factors associated with pain that also affect fatigability of skeletal muscle, are increases in extracellular K+, and decreases in pH due to metabolic by-products and lactic acid accumulation (19) . Increases in extracellular K+ decreases muscle membrane excitability resulting in decreased force production (58) . Extracellular pH decreases in muscle tissue in response to high intensity-short duration exercise, in several pain conditions (19; 29; 32; 50; 52; 52; 54) and causes hyperalgesia in both humans and animals (28; 32; 60) . Although decreases in extracellular pH have typically been thought to enhance fatigue, recent work suggests that these decreases may protect against fatigue (14) . When the extracellular pH is decreased, muscle cells depolarize and prevent the movement of Na + out of Gender, sex hormones, and muscle fiber types can influence the fatigability of muscle. In human subjects, males have greater overall strength, but can fatigue to a greater extent than females in a task-dependent manner (22; 27; 31) . When males and females are matched for strength, women fatigued less than men during intermittent contractions but performed similarly during sustained low intensity contractions males (27) . In contrast, several studies show an increase in muscle strength following testosterone replacement therapy in men with low levels of testosterone (5; 6; 18); and testosterone enhances force and resistance to fatigue in normal males (2; 65) . In parallel, androgen receptors are located on muscle fibers (1; 42) and long term treatment of orchidectomized male mice with testosterone alters the neuromuscular junction to enhance synaptic efficacy (43) . The effect of fatigue after testosterone treatment is muscle type-specific being observed in the soleus muscle, Type I fibers, but not in the extensor digitorum longus muscle, Type II fibers (2) . This suggests that gender differences in fatigability could be related to effects of testosterone on fiber types. Reports on the existence of differences in muscle fiber types between genders is conflicting with some studies showing no differences (20; 63) and others showing females with a greater portion of Type I fibers than males (59) . Due to the discrepancy in the literature, this study examined if differences in muscle fiber types between male and female mice could account for fatigue differences between genders.
The purpose of this study was to assess the influence of sex and the deficiency of ASIC3 in the development of exercise-induced muscle fatigue. We tested the hypothesis that ASIC3 -/-mice would be more fatigable than ASIC3 +/+ mice in a sex-and task-dependent manner. This study is the first to suggest that both ASIC3 and testosterone are important in the protection against the development of muscle fatigue.
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Fatigue Task 1. The first muscle fatigue task had mice run 3 times for 1 h on each run, with a 15 minute rest after run 1 and a 10 minute rest after run two. Mice were placed on the Rota-Rod (IITC Life Science Inc., Woodland Hills, CA) and were run at speeds ramping from 13-20 rpm in 180 seconds, and maintained at 20 rpm for a total duration of 1 hour run time. Mice were allowed to rest for 15 minutes and then were placed on the Rota-Rod and run at speeds ramping from 13-20 rpm in 180 seconds and maintained at 20 rpm for a total duration of 1 hour. After 10 minutes rest, mice were placed on the Rota-Rod for the final run at speeds ramping Task 2 for each condition tested.
Grip Force Protocol. In the same animals, fatigue was tested by measuring grip force. Fatigue was confirmed by measurement of grip force immediately after the fatigue task by comparing to the grip force prior to the fatigue task for both the hindlimbs and the forelimbs. Mice were trained 2 days prior to data collection to the grip force device. Mice were pulled by the tail to read grip force on the forelimb and then pulled to read grip force on hindlimb. Grip force was measured before, immediately, and 1h and 2h after the 3 rd run. Grip force was analyzed on both the forelimbs and hindlimbs and an average of 5 trials recorded. Each mouse had forelimb and hindlimb grip force measured before moving on to the next mouse. A decrease in grip force after running was interpreted as muscle fatigue.
Surgery.
Ovariectomized ASIC3 +/+ Mice. Female mice were ovariectomized according to previously published procedures (55) . Mice were anesthetized with isoflurane (3%) and a small incision was made in the abdomen and the uterine horns were lifted out of the body cavity. The ovaries were snipped off the uterine horns along with attached connective tissue. The incision was closed by suturing with 5-0 silk. The acclimation training and testing of the mice was performed 1 week after surgery.
Ovariectomized Mice and Testosterone. Mice were ovariectomized as described above. The training and testing of the mice were performed 1 week after surgery. Before testing on the third day, the ovariectomized mice were given testosterone (Sigma, St Louis MO, 30mg/kg s.c.), based on previous literature (21) . Testing and data collection were done one hour after the testosterone injection. 
Protocols for Fatigue Tasks

Measurement of Testosterone.
Mouse blood was collected into heparinized hematocrit tubes by retro-orbital puncture of mice anesthetized with isoflurane (Hospira, Inc., Lake Forest, IL). Plasma was separated from blood by centrifugation at 800 g for 15 min at room temperature. Testosterone concentrations of plasma samples, each tested in quadruplicate,
were determined with an ELISA kit (Neogen Corp., Lexington, KY). Prior to testing, plasma samples were extracted with ethyl ether, and prepared according to the manufacturer's instructions.
ATPase staining.
The gastrocnemius, soleus, and plantaris muscles were collected from each of 3 male and 3 female C57Bl/6J mice. Before dissection, each mouse was deeply anesthetized with sodium pentobarbital (150 mg/kg, i.p.), decapitated, and excess blood was drained. A thin piece of cork was placed beneath the intact muscle and pins were placed through the tendons at both ends of the muscle through the cork, before excising, to keep the 
Statistical Analysis.
Statistical calculations were performed with SPSS 16.0 software. Repeated measures ANOVA compared for differences between groups and across time for the fatigue data. The number of falls and time to task failure was analyzed with a univariate ANOVA for Fatigue task, genotype, sex, and testosterone administration. Posthoc testing compared differences between individual groups. All of the statistical results were expressed as mean ± S.E.M. Differences were considered to be significant when P < 0.05.
RESULTS
Baseline grip force measurements.
Grip force before the fatigue tasks is shown in Table 1 . There were no differences between male and female ASIC3 +/+ or ASIC3 -/-mice for either the hindpaw or the forepaw. Ovariectomizing mice increased grip force for the forepaw but not the hindpaw, while administration of testosterone in ovariectomized ASIC3 +/+ and ASIC3 -/-mice significantly increased the grip force for both the hindpaw and forepaw when compared to untreated ASIC3 +/+ and ASIC3 -/-mice (p<0.05).
Fatigue responses in ASIC3 +/+ mice and ASIC3 -/-mice
The number of times the mouse fell off of the Rota-Rod was significantly different between ASIC3 -/-mice and ASIC3 +/+ mice (p=0.003) ( and was similar to the male ASIC3 +/+ mice. However, adding testosterone to ovariectomized ASIC3 -/-mice had no effect on the fatigue response when compared to ovariectomized ASIC3 +/+ mice (hindpaw and forepaw p=0.001) (Figure 1 ). Recovery from fatigue was also significantly slower in the ovariectomized mice (hindpaw 1 h p=0.05; 2h p=0.01; forepaw 1 h p=0.003; 2 h p=0.03), and in the ovariectomized mice with testosterone (hindpaw 1h and 2 h p=0.0001; forepaw (1h p=0.001; 2h p=0.01) (Figure 1 ).
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Fatigue Task 2. Analysis of the grip force data for the hindpaws and forepaws show that there were no significant differences between groups, i.e. males, females, ovariectomized, and ovariectomized with testosterone ( Figure 2 ). All groups showed similar reductions in grip force and recovery.
Plasma testosterone concentration in ASIC3 +/+ and ASIC3 -/-mice.
The concentration of testosterone in the blood from male ASIC3 -/-mice was significantly less than that of male ASIC3 +/+ mice (p=0.018). Testosterone in the ASIC3 +/+ mice averaged 1.2 + 0.4 ng/ml and that for ASIC3 -/-mice was 0.22 + 0.1 ng/ml. For comparison, testosterone measured in an additional three female ASIC3 +/+ mice averaged 0.12 + 0.07 ng/ml and was similar to the male ASIC3 -/-mice.
Muscle fiber type in male and female ASIC3 +/+ mice. Analysis of the fiber types in both females and males showed no difference in fiber types between males and females. The percentage of fiber types were as followed: Type I male 3.0% + 
DISCUSSION
Fatigue Tasks
The current study showed that we could produce exercise-induced fatigue, defined as a decrease in muscle force, with two different fatigue tasks. These tasks resulted in different fatigue levels among male ASIC3 +/+ mice with less fatigue for the long duration task, 3-1 h runs, compared to the shorter fatigue duration task, 3-30 min runs. Although there were similar amounts of falls between the two tasks, the ASIC3 -/-mice fell more often than the ASIC3 +/+ mice. As expected the total time the mice ran were longer for the longer duration task (Fatigue Task 1), and there were no differences in the time to develop fatigue between the ASIC3 -/-mice and the ASIC3 +/+ for each of the two tasks. Similar amounts of fatigue were found between female ASIC3 +/+ mice in the two fatigue tasks. Interestingly, both male and female mice, regardless of genotype or treatment, performed similarly between the two tasks in terms of number of falls and the time to task failure. It is possible that with increasing fatigue the male mice are unable to perform the task as a result of a loss in motor coordination to a greater extent than the female mice. The Rota-Rod is commonly used to test coordination and motor performance in rodents at a gross level. To test motor performance, mice are run on a Rota-Rod for shorter durations (1-5 minutes), and at higher maximal speeds (up to 45 rpms) (7;10; 35) than that used in the current study. Further, in human subjects, fatigue affects coordination resulting in changes in firing patterns of muscles; however, there are no apparent gender differences in abilities to perform the exercise related tasks (12; 17). Together, our data suggests that there was no difference in the ability to perform the fatigue tasks between male and female mice, irrespective of genotype, despite different levels of fatigue. The long-duration fatigue tasks on the Rota-Rod used in the current study are uniquely different from previously published fatigue protocols in animals which typically involve spontaneous wheel running (72) , treadmill running (9; 49), or electrical stimulation of isolated muscles (2; 49).
The current study shows that ASIC3 -/-mice fatigue more than ASIC3 +/+ mice in males, but not females, in a task-dependent manner. The differences in fatigue in the male ASIC3 -/-mice was only evident with the longer duration fatigue task, i.e. Fatigue task 1: 3, 1h runs. In both tasks the animals were able to complete the first 2 runs without reaching fatigue; but were generally not able to complete the third run. Thus, the animals in Fatigue Task 1 ran substantially longer than those in Fatigue Task 2. There was a greater fatigue observed in females than male mice in the longer duration fatigue task (Fatigue Task 1) which was surprising given prior data showing fatigability is greater in males than in female human subjects (22; 24; 27; 38; 66) . However, in human studies, differences in the development of muscle fatigue between sexes are task-dependent (31) .
Women that are strength-matched to men could perform a greater number of intermittent contractions before they fatigued but they perform similarly when asked to sustain a submaximal voluntary contraction (31).
In our animal study, the lack of differences in the shorter duration fatigue task (Fatigue Task 2) suggests that fatigue and differences in fatigue are dependent on the duration of the task itself. Several clinical studies show differences in fatigue based on variations of the task, the intensity of exercise, and the muscle group involved (11; 24; 30) . Specifically, a 2 h running task results in fatigue in the knee flexors and extensors but not the hip muscles, shows different muscle groups respond differently to fatigue (24 (11) . However, the current study measuring grip force involves multiple muscle groups and suggests that the effect is not related to muscle fiber type or specific muscle groups. Further, in the current study, examination of muscle fiber types in the calf muscles show there were no differences between male and female mice in the distribution of Type I, IIa, IIb or IIc fibers.
Interactions between ASIC3 and testosterone
Our data shows that plasma testosterone is reduced in male ASIC3 -/-mice compared to male ASIC3 +/+ mice, and that exogenous administration of testosterone protects females from fatigue in ASIC3 +/+ mice but not ASIC3 -/-mice. This data therefore supports the hypothesis that both ASIC3 and testosterone are required to protect from fatigue in the longer duration exercise regimen. It further suggests that testosterone production, and/or secretion, is influenced by ASIC3, most likely in the testes. The lack of effect of testosterone in ASIC3 -/-mice suggests an interaction between the androgen receptor and ASIC3 in the muscle, either directly or indirectly. ASIC3 has been found in the testes (3) and testosterone regulates expression of other ion channels (i.e. calcium channels) in skeletal, cardiac and smooth muscle (8; 25; 40; 47) .
Fatigue is reduced in female mice that were ovariectomized and administered testosterone s.c., and is consistent with studies in male mice which show that increased levels of testosterone increased muscle force, and in some cases reduced muscle fatigue (2; 65). Further, testosterone increases intracellular calcium in myocytes producing increases in phosphorylation and transcription factors through a G-protein linked receptor (16) . In agreement, testosterone administration to myocytes decreases the action potential threshold and increases synaptic facilitation resulting in an enhancement of synaptic efficiency in the flexor carpi radialis muscle of the frog (43) . Thus, testosterone can have relatively fast effects on the function of the myocyte that would affect the efficacy of synaptic transmission through phosphorylation of ion channels. Increases in transcription factors could enhance the production of ion channels or androgen receptors which could also increase membrane excitability. Exercise alters androgen receptor expression in mice depending on muscle fiber type by increasing expression in Type II, and decreasing expression in Type I fibers (15) . We hypothesize that testosterone, through intracellular signaling pathways, increases efficacy of ASIC3 and/or increases production of ASIC3 to reduce fatigue allowing myocytes to contract with a lower motor neuron output.
There are many mechanisms of muscle fatigue, both peripheral and central. Peripherally, extracellular changes in the microenvironment of ions (K + , H + , Na + ) can enhance fatigue, or in some cases protect against fatigue (14;
19; 53). For example, increases in extracellular K + that occur during exercise, would activate and depolarize muscle cells resulting in an inactivation of sodium channels, and a reduction in force (53) . We suggest that H + ions play a critical role in fatigue and recovery from fatigue through activation of ASIC3 on muscle fibers.
Excitability of muscle fibers is modified by the Na + /K + transporter and depends on extracellular K + concentration (46) . Depolarization could inactivate voltage-sensitive sodium channels and produce fatigue (56; 58). Thus, exercise that increases extracellular K + may depolarize muscle cells resulting in inactivation of sodium channels and decreased excitability of muscle fibers. The Na + /K + gradient across the membrane is critical for generation of action potential amplitude (46) . By mimicking extracellular sodium decreases and potassium increases in muscle, reducing the gradients for Na + and K + , there is a reduction in the M-wave similar to that observed with fatiguing contractions (48) . Restoring the sodium gradient through activation of ASICs could potentially improve the Na + /K + gradient to reduce fatigue. Prior studies show that amiloride and benzamil, non-selective antagonists of ASIC channels, enhanced the development of fatigue (74) . These studies concluded that the Na + /H + transporter played a role in this response. However, since amiloride and benzamil also inhibit ASICs it could be interpreted that ASICs were involved in the changes in pH and the development of muscle fatigue. Prior studies also show that increases in lactic acid and H + have protective effects on muscle excitability and restores the K + -induced decrease in force (14; 45) . These data are consistent with the current study that shows enhanced muscle fatigue and slower recovery from fatigue in the male ASIC3 -/-mice in the longer-duration fatigue task.
Clinical Implications and Perspective
Fatigue in clinical conditions is generally measured subjectively and is a whole body feeling of muscle fatigue and loss of energy. This type of fatigue is common in several chronic pain conditions including fibromyalgia, osteoarthritis and rheumatoid arthritis (4; 13; 36; 37; 39; 64; 67; 70; 71; 73) . As many as 76% of people with chronic widespread musculoskeletal pain report fatigue; and as many as 94% of people with chronic fatigue syndromes report muscle pain (39; 71; 73) . These conditions are predominantly expressed in women and thus suggest a difference between males and females in the development of fatigue. During exercise, there is increased pain in people with chronic fatigue syndrome and in people with fibromyalgia (36; 64; 67; 70) . In an animal model of pain, induced by intramuscular injections of acidic saline, exercise increases nociceptive responses in mice during a long-duration fatigue task (72) . These data suggest an overlap between fatigue and pain such that fatigue plays a significant role in the development of pain; and that pain is enhanced in response to fatigue. Further, the nociceptive response to intramuscular injections of acidic saline, or to muscle inflammation is reduced in ASIC3 -/-mice, both males and females (61; 62) . Since both fatigue and muscle pain involve ASIC3, a common pathway may occur in the periphery to generate the pain and fatigue associated with chronic muscle pain conditions. It should be noted, however, that most studies in clinical syndromes measure fatigue as a whole body feeling of a loss of energy using subjective scales. However, the current study measured fatigue as a temporary reduction in force as a result of exercise. Muscle fatigability has been measured in people with fibromyalgia and chronic fatigue syndrome in response to high intensity exercise. Interestingly, in these studies there is no difference in fatigability when compared to controls for fibromyalgia patients but there is for chronic fatigue syndrome (4; 13; 26; 37) . This may be related to the task performed, and longer duration tasks may be necessary to observe differences in the clinical population. Subjects do show a decrease in muscle strength and this reduction in strength may contribute to the overall feeling of fatigue (4; 13; 33; 34; 37; 69) .
Future studies should assess endurance and low intensity exercise tests in clinical populations that have pain and fatigue.
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